FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy
Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?
Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll
BMS Team Celebrates Accelerated FDA Approval for Multiple Myeloma
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg
Lucy Davis Reveals Incurable Stage 4 Breast Cancer: Diagnosis, Bone Metastases, and What We Know
LITESPARK-011 Trial: Belzutifan Plus Lenvatinib vs Cabozantinib in Advanced RCC
